141 related articles for article (PubMed ID: 33067739)
21. ACTL6A promotes repair of cisplatin-induced DNA damage, a new mechanism of platinum resistance in cancer.
Xiao Y; Lin FT; Lin WC
Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33408251
[TBL] [Abstract][Full Text] [Related]
22. Knockdown of YAP inhibits growth in Hep-2 laryngeal cancer cells via epithelial-mesenchymal transition and the Wnt/β-catenin pathway.
Tang X; Sun Y; Wan G; Sun J; Sun J; Pan C
BMC Cancer; 2019 Jul; 19(1):654. PubMed ID: 31269911
[TBL] [Abstract][Full Text] [Related]
23. Regulation of laryngeal squamous cell cancer progression by the lncRNA H19/miR-148a-3p/DNMT1 axis.
Wu T; Qu L; He G; Tian L; Li L; Zhou H; Jin Q; Ren J; Wang Y; Wang J; Kan X; Liu M; Shen J; Guo M; Sun Y
Oncotarget; 2016 Mar; 7(10):11553-66. PubMed ID: 26872375
[TBL] [Abstract][Full Text] [Related]
24. ACTL6A expression promotes invasion, metastasis and epithelial mesenchymal transition of colon cancer.
Zeng Z; Yang H; Xiao S
BMC Cancer; 2018 Oct; 18(1):1020. PubMed ID: 30348114
[TBL] [Abstract][Full Text] [Related]
25. Zinc finger protein x-linked (ZFX) contributes to patient prognosis, cell proliferation and apoptosis in human laryngeal squamous cell carcinoma.
Yang F; Ma H; Feng L; Lian M; Wang R; Fan E; Fang J
Int J Clin Exp Pathol; 2015; 8(11):13886-99. PubMed ID: 26823701
[TBL] [Abstract][Full Text] [Related]
26. Actin-like 6A predicts poor prognosis of hepatocellular carcinoma and promotes metastasis and epithelial-mesenchymal transition.
Xiao S; Chang RM; Yang MY; Lei X; Liu X; Gao WB; Xiao JL; Yang LY
Hepatology; 2016 Apr; 63(4):1256-71. PubMed ID: 26698646
[TBL] [Abstract][Full Text] [Related]
27. Targeting SKA3 suppresses the proliferation and chemoresistance of laryngeal squamous cell carcinoma via impairing PLK1-AKT axis-mediated glycolysis.
Gao W; Zhang Y; Luo H; Niu M; Zheng X; Hu W; Cui J; Xue X; Bo Y; Dai F; Lu Y; Yang D; Guo Y; Guo H; Li H; Zhang Y; Yang T; Li L; Zhang L; Hou R; Wen S; An C; Ma T; Jin L; Xu W; Wu Y
Cell Death Dis; 2020 Oct; 11(10):919. PubMed ID: 33106477
[TBL] [Abstract][Full Text] [Related]
28. Aberrant methylation-mediated downregulation of lncRNA SSTR5-AS1 promotes progression and metastasis of laryngeal squamous cell carcinoma.
Wang B; Zhao L; Chi W; Cao H; Cui W; Meng W
Epigenetics Chromatin; 2019 Jun; 12(1):35. PubMed ID: 31196171
[TBL] [Abstract][Full Text] [Related]
29. The crosstalk between AXL and YAP promotes tumor progression through STAT3 activation in head and neck squamous cell carcinoma.
Li J; Shi C; Zhou R; Han Y; Xu S; Ma H; Zhang Z
Cancer Sci; 2020 Sep; 111(9):3222-3235. PubMed ID: 32589311
[TBL] [Abstract][Full Text] [Related]
30. Elevated expression of yes‑associated protein is associated with the malignant status and prognosis of laryngeal squamous cell carcinoma.
Pan C; Du Z; Cai Z; Liu Y; Sun Y; Chen J; Tong T; Chen Q; Zhou L; Bing D; Tao Y; Chu H
Mol Med Rep; 2017 Oct; 16(4):4934-4940. PubMed ID: 28791393
[TBL] [Abstract][Full Text] [Related]
31. NFBD1/MDC1 participates in the regulation of proliferation and apoptosis in human laryngeal squamous cell carcinoma.
Liu X; Qiu Z; Wang Z; Zuo W; Gong Z; Liu C; Zeng Q; Qian Y; Jiang L; Li Y; Bu Y; Hu G
Clin Transl Oncol; 2018 Apr; 20(4):534-541. PubMed ID: 28921460
[TBL] [Abstract][Full Text] [Related]
32. miR-506 is a YAP1-dependent tumor suppressor in laryngeal squamous cell carcinoma.
Gao C; Hu S
Cancer Biol Ther; 2019; 20(6):826-836. PubMed ID: 30907227
[TBL] [Abstract][Full Text] [Related]
33. TRIP6 accelerates the proliferation and invasion of cervical cancer by upregulating oncogenic YAP signaling.
Yang F; Li L; Zhang J; Zhang J; Yang L
Exp Cell Res; 2020 Nov; 396(1):112248. PubMed ID: 32853630
[TBL] [Abstract][Full Text] [Related]
34. ACTL6A interacts with p53 in acute promyelocytic leukemia cell lines to affect differentiation via the Sox2/Notch1 signaling pathway.
Zhong PQ; Zhong L; Yao JJ; Liu DD; Yuan Z; Liu JM; Chen M; Yao SF; Zhao Y; Liu L; Li LW; Liu BZ
Cell Signal; 2019 Jan; 53():390-399. PubMed ID: 30448346
[TBL] [Abstract][Full Text] [Related]
35. SIRT4 expression in laryngeal squamous cell carcinoma.
Wan W; Li Y; Zhou C; Sun B; Yang S; Zhou C
Pharmazie; 2020 Dec; 75(12):646-650. PubMed ID: 33303058
[TBL] [Abstract][Full Text] [Related]
36. The role of α-smooth muscle actin in confirming the microinvasion of laryngeal squamous cell carcinoma.
Bai Y; Yue C; Lu Z; Li P; Liu H
Ann Diagn Pathol; 2021 Oct; 54():151804. PubMed ID: 34419855
[TBL] [Abstract][Full Text] [Related]
37. Actin-like protein 6A/MYC/CDK2 axis confers high proliferative activity in triple-negative breast cancer.
Jian Y; Huang X; Fang L; Wang M; Liu Q; Xu H; Kong L; Chen X; Ouyang Y; Wang X; Wei W; Song L
J Exp Clin Cancer Res; 2021 Feb; 40(1):56. PubMed ID: 33541412
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma.
Li JZ; Gao W; Lei WB; Zhao J; Chan JY; Wei WI; Ho WK; Wong TS
Oncotarget; 2016 Sep; 7(36):58218-58233. PubMed ID: 27533461
[TBL] [Abstract][Full Text] [Related]
39. Targeting FoxM1 by thiostrepton inhibits growth and induces apoptosis of laryngeal squamous cell carcinoma.
Jiang L; Wu X; Wang P; Wen T; Yu C; Wei L; Chen H
J Cancer Res Clin Oncol; 2015 Jun; 141(6):971-81. PubMed ID: 25391371
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-4497 functions as a tumor suppressor in laryngeal squamous cell carcinoma via negatively modulation the GBX2.
Chen X; Zhang L; Tang S
Auris Nasus Larynx; 2019 Feb; 46(1):106-113. PubMed ID: 29843929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
